Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
Alan Tan, MD, discusses the nuances of navigating combination regimens for patients with advanced renal cell carcinoma.
Chad Tang, MD, discusses unanswered questions surrounding the role of radiation therapy in renal cell carcinoma.
During a Case-Based Roundtable® event, Bradley McGregor, MD, moderated a discussion on prognosis and treatment approaches for a patient with stage IV
papillary renal cell carcinoma.
Review data demonstrated a variation in opioid prescriptions for cancer-related pain between oncology providers and pain management providers.
Clear cell renal cell carcinoma (ccRCC) is characterized by Von Hippel Lindau (VHL) gene loss of function mutation, which leads to the accumulation of hypoxia-inducible factor 2α (HIF2α). HIF2α has been well-established as one of the major oncogenic drivers of ccRCC, however, its therapeutic ...
During separate virtual live events, David A. Braun, MD, PhD, and Rana R. McKay, MD, surveyed oncologists on options for a patient with clear cell renal cell carcinoma (RCC) in the front line.
Chad Tang, MD, discusses how radiation could play a role in advanced renal cell carcinoma.
Chad Tang, MD, discusses how radiation could play a role in advanced renal cell carcinoma.
NKT2152, a novel HIF2α inhibitor, produced responses in heavily pretreated advanced clear cell renal cell carcinoma.
An expert explained how radiation may be a treatment option for patients with renal cell carcinoma to manage symptoms and control the disease.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.